Status:
COMPLETED
The Effect of Laparoscopic Splenectomy on the Immune Function for Cirrhosis Patients
Lead Sponsor:
Northern Jiangsu People's Hospital
Conditions:
Cirrhosis, Liver
Splenectomy; Status
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study, the investigators compared the improvement of and azygoportal disconnection related indicators in patients with liver cirrhosis after laparoscopic splenectomy. To determine whether surg...
Detailed Description
The patients were enrolled according to the research criteria, and collected the general basic information of the patients. After the preoperative preparation was perfected, the same surgical team per...
Eligibility Criteria
Inclusion
- A clinical, radiological or histologic diagnosis of cirrhosis of any etiology
- Splenomegaly with secondary hypersplenism, Platelet count \< 50\*10\^9/L
- Informed consent to participate in the study
Exclusion
- Hepatocellular carcinoma or any other malignancy,
- Child-Pugh grade C
- Recent peptic ulcer disease
- History of Hemorrhagic stroke
- Pregnancy.
- Uncontrolled Hypertension
- Bleeding portal hypertension
- Human immunodeficiency virus (HIV) infection
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2024
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT05339269
Start Date
March 1 2022
End Date
November 30 2024
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Medical College, Yangzhou University
Yangzhou, Jiangsu, China, 225001